This inventor holds 6 USPTO granted patents and 1 published patent application, plus 4 CIPO patents. Top assignee: Glaxo Wellcome Inc.. Active years: 1996-2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996-2001
Title: Inventor Spotlight on Robert Carl Andrews
Introduction
Robert Carl Andrews is a distinguished inventor based in Durham, NC, USA. With a remarkable portfolio that includes six patents, Andrews has made significant contributions to the field of therapeutics, particularly through his innovative use of formamide compounds.
Latest Patents
Andrews' latest work centers on "Formamide compounds as therapeutic agents." This family of compounds features a general structural formula aimed at harnessing the medicinal properties of formamide, showcasing his commitment to advancing pharmaceutical research and development.
Career Highlights
Currently employed at Glaxo Wellcome Inc., Andrews has played a pivotal role in various research initiatives. His work not only emphasizes the importance of innovative medicinal chemistry but also reflects his dedication to improving healthcare solutions through effective compounds.
Collaborations
Throughout his career, Andrews has collaborated with notable colleagues, including Marc W. Andersen and David John Cowan. These partnerships highlight the collaborative nature of scientific research and the importance of teamwork in the pursuit of groundbreaking innovations.
Conclusion
In summary, Robert Carl Andrews stands out as a prominent figure in the realm of invention, particularly in the development of therapeutic agents. His ongoing contributions and collaborations at Glaxo Wellcome Inc. underline the impact of inventors in advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile